Rethinking Diabetes Drug Discovery
With Dr Keld Fosgerau, Consultant
The diabetes pandemic is a reality, currently affecting around 462 million people worldwide and growing rapidly. Where are the next medicines being developed, and what are the un-met medical needs still existing?